Over a period of six months all reports in the South Tees Health District of serum calcium levels greater than 2.70 mmol/l were extracted and patient records examined to establish the associated diseases and patterns of management. A total of 235 reports were evaluated, and after exclusion of doubtful cases 196 patients were included in the study. No cause had been identified in 57 (29%). Many of these were elderly females in whom hypercalcaemia may have been due to primary hyperparathyroidism, but parathyroid hormone levels had not been measured. Of those in whom a diagnosis had been made, 62 (45%) were associated with malignancy and 50 (36%) with chronic renal failure. 72% of cases of hypercalcaemia reported to general practitioners and 13% of those reported to hospital doctors were not investigated further. Despite the inclusion of serum calcium estimation on routine biochemical profiles, many cases of hypercalcaemia are being ignored or not investigated further. The study emphasizes the need for a reliable screening test for primary hyperparathyroidism.
Introduction
The causes of hypercalcaemia and the diseases associated with it have been the subject of many studies, but the exact incidence of hypercalcaemia in the United Kingdom is still uncertain. Population surveys in various countries have suggested a prevalence of between 1:200 and 1: 1000, with primary hyperparathyroidism accounting for more than half the cases (McGeown & Morrison 1959 , Keating 1961 , McLellan et al. 1968 , Boonstra & Jackson 1971 , Stenstrom & Heedman 1974 , Christensson et al. 1976 , Mundy et al. 1980 ). Many of the early studies were performed in centres with a special interest in calcium-related disease, such as renal or endocrine units, but the advent of multichannel autoanalysers has allowed the detection of previously unsuspected hypercalcaemia in asymptomatic subjects and it has become clear that the true incidence has been seriously underestimated. Christensson et al. (1976) screened 15 903 apparently healthy subjects in Stockholm and found persistent hypercalcaemia in 6%. Hyperparathyroidism was present in 3.6%. , in Rochester, USA, found 7.8 new cases of primary hyperparathyroidism annually per 100000 population in 1965-74, but after the introduction of routine measurement of serum calcium levels the rate rose to 51.1 per 100 000 and was as high as 188 per 100000 in women aged 60 or more.
Recent surveys in the UK have chiefly come from the Queen Elizabeth Hospital, Birmingham, where the endocrine unit provides a specialist referral service with a particular interest in hyperparathyroidism. Fisken et al. (1981) found 51 cases of primary hyperparathyroidism in a group of 166 patients with hypercalcaemia seen in one year, while Mundy et al. (1980) suggested an incidence of hyperparathyroidism of 25 per 100000 per year. They were uncertain whether these results were representative of other hospitals or other centres .
We have performed a survey of hypercalcaemia in Cleveland, an area served by several general hospitals but with no such special interest in calcium metabolism or parathyroid 'Accepted 31 May 1984 2Present address: District General Hospital, Sunderland disease. Our aim was to examine the prevalence of hypercalcaemia, to establish the aetiology or associated diseases and to document patterns of management.
Methods
The Department of Chemical Pathology at Middlesbrough General Hospital receives samples for analysis from the hospitals and general practitioners in the South Tees Health District, a population of approximately 350000. Reports of serum calcium levels, measured with a Technicon-SMAC autoanalyser, were collected daily for a 6-month period. The upper limit of normal for serum calcium is regarded as 2.60 mmol/l, but for the purposes of the study only subjects with corrected serum calcium levels greater than 2.70 mmol/I were included. The correction factor used was that described by Payne et al. (1973) . No attempt was made to ascertain the procedures adopted at the time of collection of blood.
Clinical details of hypercalcaemic subjects were extracted from case records (AR) and where investigations were incomplete they were followed to completion over a period of nine months. Since this was designed as a prevalence study, no steps were taken to exclude those subjects known to have hypercalcaemia before the survey commenced.
The study protocol was approved by the Ethical Committee of the South Tees Health District. Table I gives the number of patients included in the study. Of those with a corrected serum calcium greater than 2.70 mmol/l, 15 were lost to follow up and 24 had a normal calcium on repeat testing. The study sample thus consisted of 196 subjects, whose age and sex distribution is given in Table 2 . There was a 3:2 predominance of females in the overall sample but the ratio showed an obvious age gradient from 1: 1 in the 15-44 age group to 3: 1 in those over 65. Table 3 shows the range of serum calcium levels in the same age groups; 92% of the subjects had serum calcium levels below 3.0 mmol/l and only 15 subjects had levels greater than 3.5 mmol/l.
Results
A diagnosis had been made in 139 patients (71 %) and the distribution is shown in Table  4 . Malignancy was the commonest associated condition (45%), followed by chronic renal disease (36%). latrogenic causes, such as diuretic therapy or calcium and vitamin D therapy, apparently accounted for the hypercalcaemia in 8 patients. Of the 57 patients in whom no cause for the hypercalcaemia had been discovered, 65% were over the age of 65. Table 5 indicates the sites of malignant neoplasms. The distribution is similar to that observed in previous studies (McLellan et al. 1968 .
Of the few requests from general practitioners, 25 patients (12%) were found to have hypercalcaemia. Eighteen of these were not investigated further. In 4 cases no further investigations were requested despite persistently elevated serum calcium levels. In all 7 patients who were investigated further, a probable cause for the hypercalcaemia was found.
Discussion
This study has confirmed that there are still many cases of unsuspected hypercalcaemia in the population. During the 6-month study period, the Department of Chemical Pathology at Middlesbrough General Hospital received approximately 32 000 requests for a biochemistry profile in which a serum calcium estimation was included. There were 359 cases in which the serum calcium was greater than 2.60 mmol/l (1.1%). In order to eliminate falsely elevated serum calcium levels and cases of doubtful significance, we studied only those patients with corrected serum calcium levels greater than 2.70 mmol/l. This also allowed comparison of our results with those of Fisken et al. (1980) , who performed a retrospective study of hospital inpatients. They found 496 cases of hypercalcaemia in a period of 2 years 8 months (3.6 cases per week), whereas we found 196 cases in 6 months (7.5 cases per week). Our high prevalence rate can be attributed to two factors: first, the survey included both inpatients and outpatients, as well as requests from general practitioners; secondly, South Cleveland Hospital houses the sub-regional radiotherapy and renal units, where many of the hypercalcaemic patients were attending for haemodialysis or radiotherapy for malignant disease. If those patients attending these specialized units are excluded, the incidence of hypercalcaemia is 3.1 new cases per week, which is slightly higher than the 2 cases per week suggested by Fisken et al. (1980) for a similar non-selected population. The incidence of malignancy in our series is much as expected in a hospital population. Hypercalcaemia rarely precedes malignancy and most patients have metastases by the time the hypercalcaemia is first noted. Malignancy accounted for 66% of those with serum calcium levels greater than 3.5 mmol/l.
Eight cases (5.75%) were attributed to iatrogenic causes, such as calcium and vitamin D therapy, or thiazide diuretics. As in the study by Fisken et al. (1980) , only one case of sarcoidosis was found.
In the present study 29% of patients with-hypercalcaemia remained undiagnosed at the end of the study period. Many of these were asymptomatic elderly females, with serum calcium levels between 2.70 and 3.0 mmol/l. In the study by Fisken et al. (1980) , 22% were still undiagnosed after a period of 2 years 8 months. The authors proceeded to a prospective study in which they found that 91% of cases of hypercalcaemia could be attributed to malignancy or hyperparathyroidism (Fisken et al. 1981) . Of 57 patients in whom the diagnosis was uncertain at presentation, 14 were found to have malignancy and 28 were subsequently found to have hyperparathyroidism either by demonstration of a parathyroid adenoma or by finding elevated immunoreactive parathyroid hormone (PTH) No diagnosis made 57 levels. They concluded that 30% of cases of hypercalcaemia in their hospital population were attributable to primary hyperparathyroidism. These and our results substantiate the views of Stenstr6m & Heedman (1974) that many patients with primary hyperparathyroidism are elderly females and that a long period of follow up is required before the diagnosis is confirmed. In our study primary hyperparathyroidism had been confirmed in only 75% by the end of the study period, but we suspect that primary hyperparathyroidism accounts for many of the undiagnosed cases of hypercalcaemia. It is unfortunate that there is no simple screening test for hyperparathyroidism and that multivariate analysis has proved relatively unhelpful (Fisken et al. 1981) . Even PTH immunoassay may be unreliable; it is not universally available and differentiation between malignant disease and primary hyperparathyroidism may vary with different PTH immunoassays (Raisz et al. 1979) .
It is our belief that many cases of hypercalcaemia and hyperparathyroidism are still being missed in the general population. Most of these appear to be elderly females, many of whom may be asymptomatic.
Symptoms of hypercalcaemia are often subtle and may be attributed to other conditions. Several authors (Peskin et al. 1978 have suggested that parathyroidectomy is well tolerated by elderly patients and should be considered if symptoms are present; in their patients parathyroidectomy led to symptomatic improvement. Recently van't Hoff et al. (1983) studied a group of patients with hyperparathyroidism who were treated conservatively and found no evidence of deterioration over a mean period of 4.2 years. They suggest that patients over the age of 60 with mild asymptomatic hyperparathyroidism may not require surgery. Adams (1982) has published similar findings.
One of the striking features of the present study was the relative lack of follow up of patients reported as having hypercalcaemia. Serum calcium levels greater than 2.70 mmol/l were apparently ignored in 72% of general practitioner cases, and in 13% of hospital cases Primary unknown I Kidney no further investigation was ordered. While marginally raised levels may not require intensive investigation, persistently elevated levels should at least be investigated by means of fasting calcium levels and chest X-ray, unless the cause is already known. There is clearly a need for a reliable and reproducible diagnostic test for hyperparathyroidism, while PTH immunoassay should be more widely available. Only prolonged follow up of patients with asymptomatic hypercalcaemia will allow us to decide whether medial management is adequate or whether surgical exploration of the neck is required.
From the present survey we cannot draw any conclusions about the incidence of hypercalcaemia or hyperparathyroidism in the general population, but our study confirms the findings of others that asymptomatic hypercalcaemia is relatively common; that malignancy is the main associated condition in a hospital population; and that the diagnosis of hyperparathyroidism now most frequently follows the incidental finding of hypercalcaemia during the routine biochemical investigation of some other condition.
